Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR Patients

NCT05642793 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT05642793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05642793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR Patients
Lead sponsor
Peking University Third Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
April 1, 2022
Completion date
March 1, 2024
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

proliferative diabetic retinopathy